Review highlights how evolving breast biopsy markers optimize surgical planning and radiation targeting, indicating significant improvements in clinical workflows and cost reduction.
Breast biopsy markers have evolved from simple metallic devices to sophisticated multimaterial tools that have become essential for breast cancer care, demonstrating their clinical benefits in surgical planning, radiation targeting, and cost reduction.
No takes yet. Share an insight, caveat, or question.
Moseley et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: